Interferon β-1b for patients with moderate to severe COVID-19 in the inflammatory phase of the disease

J Med Virol. 2021 Jul;93(7):4102-4107. doi: 10.1002/jmv.26976. Epub 2021 Apr 15.
No abstract available

Publication types

  • Letter
  • Multicenter Study

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antiviral Agents / therapeutic use*
  • COVID-19 / immunology
  • COVID-19 / mortality
  • COVID-19 Drug Treatment*
  • Female
  • Humans
  • Immunologic Factors / therapeutic use*
  • Intensive Care Units
  • Interferon beta-1b / therapeutic use*
  • Male
  • Middle Aged
  • Retrospective Studies

Substances

  • Antiviral Agents
  • Immunologic Factors
  • Interferon beta-1b